Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080663296> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3080663296 endingPage "e216" @default.
- W3080663296 startingPage "e216" @default.
- W3080663296 abstract "<b>Objective:</b> Patients with chronic idiopathic vulvar vestibulitis have increased mast cells when biopsied, and cromolyn has been suggested as a treatment. The purpose of this study was to assess the efficacy of 4% cromolyn cream in women with vulvar vestibulitis. <b>Methods:</b> A prospective, double blind, randomised, placebo controlled study was initiated at two centres. Patients with vulvar vestibulitis were assigned to apply cromolyn or placebo cream to the vestibule. Symptoms (burning, irritation) and signs (erythema, extent of erythema, tenderness) were recorded on a 0–3 scale. In the sexually active patient subgroup, dyspareunia was also evaluated. <b>Results:</b> 13 of the 26 evaluable patients received cromolyn. Patients in the cromolyn arm were more likely to have failed therapy with amitriptyline (p = 0.05), but the two groups were otherwise similar upon study entry. Overall, scores decreased from a median of 9 to 5 (p = 0.001) during the study, but the level of improvement was similar between both groups. Improvement was unrelated to duration of symptoms, fluconazole use, or sexual activity. Five patients (38%) taking cromolyn and six (46%) taking placebo felt they had a 50% or greater reduction in symptoms. In the 21 sexually active patients, the total score decreased from a mean of 12 to 8 (p = 0.005), but there was no statistically significant difference between study arms. <b>Conclusions:</b> Cromolyn cream did not confer a significant benefit in patients with vulvar vestibulitis. The large placebo response suggests the need for large well controlled studies of other treatment modalities." @default.
- W3080663296 created "2020-09-01" @default.
- W3080663296 creator A5004835573 @default.
- W3080663296 creator A5056468178 @default.
- W3080663296 creator A5060117684 @default.
- W3080663296 creator A5060782749 @default.
- W3080663296 creator A5077594056 @default.
- W3080663296 creator A5080026993 @default.
- W3080663296 date "2020-08-28" @default.
- W3080663296 modified "2023-09-26" @default.
- W3080663296 title "Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian<i>et al</i>" @default.
- W3080663296 cites W3020578654 @default.
- W3080663296 cites W3023346879 @default.
- W3080663296 cites W3032373213 @default.
- W3080663296 cites W3032931487 @default.
- W3080663296 cites W3033436412 @default.
- W3080663296 cites W3043308024 @default.
- W3080663296 doi "https://doi.org/10.1136/annrheumdis-2020-218778" @default.
- W3080663296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32859609" @default.
- W3080663296 hasPublicationYear "2020" @default.
- W3080663296 type Work @default.
- W3080663296 sameAs 3080663296 @default.
- W3080663296 citedByCount "7" @default.
- W3080663296 countsByYear W30806632962020 @default.
- W3080663296 countsByYear W30806632962021 @default.
- W3080663296 countsByYear W30806632962022 @default.
- W3080663296 countsByYear W30806632962023 @default.
- W3080663296 crossrefType "journal-article" @default.
- W3080663296 hasAuthorship W3080663296A5004835573 @default.
- W3080663296 hasAuthorship W3080663296A5056468178 @default.
- W3080663296 hasAuthorship W3080663296A5060117684 @default.
- W3080663296 hasAuthorship W3080663296A5060782749 @default.
- W3080663296 hasAuthorship W3080663296A5077594056 @default.
- W3080663296 hasAuthorship W3080663296A5080026993 @default.
- W3080663296 hasConcept C116675565 @default.
- W3080663296 hasConcept C126322002 @default.
- W3080663296 hasConcept C159047783 @default.
- W3080663296 hasConcept C203014093 @default.
- W3080663296 hasConcept C2777648638 @default.
- W3080663296 hasConcept C2779123688 @default.
- W3080663296 hasConcept C2779134260 @default.
- W3080663296 hasConcept C3006700255 @default.
- W3080663296 hasConcept C3007834351 @default.
- W3080663296 hasConcept C3008058167 @default.
- W3080663296 hasConcept C524204448 @default.
- W3080663296 hasConcept C71924100 @default.
- W3080663296 hasConceptScore W3080663296C116675565 @default.
- W3080663296 hasConceptScore W3080663296C126322002 @default.
- W3080663296 hasConceptScore W3080663296C159047783 @default.
- W3080663296 hasConceptScore W3080663296C203014093 @default.
- W3080663296 hasConceptScore W3080663296C2777648638 @default.
- W3080663296 hasConceptScore W3080663296C2779123688 @default.
- W3080663296 hasConceptScore W3080663296C2779134260 @default.
- W3080663296 hasConceptScore W3080663296C3006700255 @default.
- W3080663296 hasConceptScore W3080663296C3007834351 @default.
- W3080663296 hasConceptScore W3080663296C3008058167 @default.
- W3080663296 hasConceptScore W3080663296C524204448 @default.
- W3080663296 hasConceptScore W3080663296C71924100 @default.
- W3080663296 hasIssue "11" @default.
- W3080663296 hasLocation W30806632961 @default.
- W3080663296 hasLocation W30806632962 @default.
- W3080663296 hasOpenAccess W3080663296 @default.
- W3080663296 hasPrimaryLocation W30806632961 @default.
- W3080663296 hasRelatedWork W3029462428 @default.
- W3080663296 hasRelatedWork W3030798755 @default.
- W3080663296 hasRelatedWork W3048464972 @default.
- W3080663296 hasRelatedWork W3049204579 @default.
- W3080663296 hasRelatedWork W3084498529 @default.
- W3080663296 hasRelatedWork W3134376730 @default.
- W3080663296 hasRelatedWork W3156800464 @default.
- W3080663296 hasRelatedWork W4206776697 @default.
- W3080663296 hasRelatedWork W3121947905 @default.
- W3080663296 hasRelatedWork W3127156785 @default.
- W3080663296 hasVolume "81" @default.
- W3080663296 isParatext "false" @default.
- W3080663296 isRetracted "false" @default.
- W3080663296 magId "3080663296" @default.
- W3080663296 workType "article" @default.